Logo image of ZIXI

Zix Corp (ZIXI) Stock Fundamental Analysis

NASDAQ:ZIXI - Nasdaq - Common Stock

8.485  -0.01 (-0.06%)

After market: 8.485 0 (0%)

Fundamental Rating

2

Overall ZIXI gets a fundamental rating of 2 out of 10. We evaluated ZIXI against 284 industry peers in the Software industry. ZIXI has a bad profitability rating. Also its financial health evaluation is rather negative. ZIXI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZIXI was profitable.
ZIXI Yearly Net Income VS EBIT VS OCF VS FCFZIXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 10M -10M 20M 30M

1.2 Ratios

Industry RankSector Rank
ROA -2.38%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZIXI Yearly ROA, ROE, ROICZIXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 10 -10 20

1.3 Margins

Industry RankSector Rank
OM -0.24%
PM (TTM) -4.38%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZIXI Yearly Profit, Operating, Gross MarginsZIXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ZIXI has more shares outstanding
The debt/assets ratio for ZIXI is higher compared to a year ago.
ZIXI Yearly Shares OutstandingZIXI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M 50M
ZIXI Yearly Total Debt VS Total AssetsZIXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.58, we must say that ZIXI is in the distress zone and has some risk of bankruptcy.
ZIXI has a Debt/Equity ratio of 1.37. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACCN/A
WACCN/A
ZIXI Yearly LT Debt VS Equity VS FCFZIXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M

2.3 Liquidity

ZIXI has a Current Ratio of 0.76. This is a bad value and indicates that ZIXI is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.76 indicates that ZIXI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76
ZIXI Yearly Current Assets VS Current LiabilitesZIXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

ZIXI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.35%.
ZIXI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.42% yearly.
ZIXI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.39%.
Measured over the past years, ZIXI shows a very strong growth in Revenue. The Revenue has been growing by 31.91% on average per year.
EPS 1Y (TTM)4.35%
EPS 3Y29.28%
EPS 5Y22.42%
EPS Q2Q%-11.76%
Revenue 1Y (TTM)16.39%
Revenue growth 3Y49.27%
Revenue growth 5Y31.91%
Sales Q2Q%18.25%

3.2 Future

ZIXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.20% yearly.
Based on estimates for the next years, ZIXI will show a quite strong growth in Revenue. The Revenue will grow by 14.54% on average per year.
EPS Next Y-0.53%
EPS Next 2Y6.88%
EPS Next 3Y6.07%
EPS Next 5Y6.2%
Revenue Next Year16.62%
Revenue Next 2Y15.11%
Revenue Next 3Y14.35%
Revenue Next 5Y14.54%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ZIXI Yearly Revenue VS EstimatesZIXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ZIXI Yearly EPS VS EstimatesZIXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.14, the valuation of ZIXI can be described as correct.
When comparing the Price/Earnings ratio of ZIXI to the average of the S&P500 Index (26.92), we can say ZIXI is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 12.28, the valuation of ZIXI can be described as correct.
The average S&P500 Price/Forward Earnings ratio is at 21.49. ZIXI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.14
Fwd PE 12.28
ZIXI Price Earnings VS Forward Price EarningsZIXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.57
ZIXI Per share dataZIXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2Y6.88%
EPS Next 3Y6.07%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZIXI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Zix Corp

NASDAQ:ZIXI (12/22/2021, 8:55:27 PM)

After market: 8.485 0 (0%)

8.485

-0.01 (-0.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)02-28 2022-02-28/amc
Inst Owners0.03%
Inst Owner Change0%
Ins Owners1.39%
Ins Owner Change0%
Market Cap468.20M
Analysts78
Price Target10.2 (20.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.14
Fwd PE 12.28
P/S 1.91
P/FCF N/A
P/OCF N/A
P/B 3.08
P/tB N/A
EV/EBITDA 17.57
EPS(TTM)0.6
EY7.07%
EPS(NY)0.69
Fwd EY8.14%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.45
BVpS2.76
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.63
Profitability
Industry RankSector Rank
ROA -2.38%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.24%
PM (TTM) -4.38%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z 0.58
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.35%
EPS 3Y29.28%
EPS 5Y22.42%
EPS Q2Q%-11.76%
EPS Next Y-0.53%
EPS Next 2Y6.88%
EPS Next 3Y6.07%
EPS Next 5Y6.2%
Revenue 1Y (TTM)16.39%
Revenue growth 3Y49.27%
Revenue growth 5Y31.91%
Sales Q2Q%18.25%
Revenue Next Year16.62%
Revenue Next 2Y15.11%
Revenue Next 3Y14.35%
Revenue Next 5Y14.54%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A